BioCentury-BayHelix China Healthcare Summit 2024 (A) | BioCentury | 29 October 2024 | The St. Regis Shanghai Jingan, 1008 Beijing West Road, 200041

For our 11th annual summit, we return to Shanghai to re-engage in cross-border collaboration and discussion for:
• Two days of strategic panels tailored to help busy executives understand emerging opportunities and challenges in China.
• 50+ Road Show presentations from China, Asia and Western biotechs and medtechs selected by BioCentury.
• Four days of C-level partnering: Two days in Shanghai + two days virtual
• Hybrid event: Attend in-person or virtually via the China Summit digital platform.
• McKinsey & Company returns for the 11th year as Insights Partner with an exclusive conference report on the latest trends and data shaping the bipoharma and medtech industries in China.

2024 Speakers

Joshua Berlin
Head of Corporate Alliances & Business Development, BioCentury Inc.

Harm-Jan Borgeld, Ph.D.
Global Head, Asia Partnering, Roche

Patrick Branch
Head of Business Development, Japan & APAC, Nxera Pharma

Wei William Cao, Ph.D.
Founder & Former CEO, Gracell Biotechnologies, AstraZeneca

Li Chen, Ph.D.
CEO & Executive Director, Hua Medicine Ltd.

Yan Chen, Ph.D.
Founder, President & CEO, Elpis Biopharmaceuticals

Jeff Cranmer
Executive Editor and Head of Daily Global Intelligence, BioCentury Inc.

Tim Ding
General Manager, Veeva China

David Flores
Co-Founder, President & CEO, BioCentury Inc.

Weidong Hao
Chief Scientific Officer, Singapore Experimental Drug Development Centre

Josh Hofheimer
Partner & Co-Head of Global Life Sciences Group, Sidley

Zhi Hong, Ph.D.
Chairman & CEO, Brii Bioscience

James Huang
Managing Partner, Panacea Venture

Cherry Huang
President, China, Johnson & Johnson Innovative Medicine

Zhaoyu Jin, Ph.D.
Founder & CEO, FutureGen Biopharmaceutical

Vijay Karwal
Managing Director, CBC Group

Paul Koolenbrander
CEO, Rxilient Health

Franck Le Deu
Senior Partner & Co-Leader of Asia Life Sciences Practice, McKinsey & Company

Leo Lee
President & Managing Director, China and Japan, Novartis

Jeremy Levin (林伟峻) D.Phil, MB BChir
Former Chair, Biotechnology Innovation Organization (BIO) and Chairman and CEO of Ovid Therapeutics

Bin Li, Ph.D.
Founder, CEO & Chief Investment Officer, Lake Bleu Capital

James Li, M.D.
Former Partner, Kleiner Perkins Caufield & Byers and Co-Founder & Chairman, JW Therapeutics

Xiang Li (Michael Lee), Ph.D.
Founder & CEO, XellSmart

Zili Li, M.D., MPH
Fellow, Drug Information Association, and former VP & Head of Asia Pacific R&D, Johnson & Johnson

James C. Lin
Partner, Davis Polk

Dan Liu, Ph.D.
Managing Partner, Pivotal bioVenture Partners

Lois Sheng Liu
Associate, Baker & McKenzie

Wendy Pan, Ph.D.
Partner & Leader of Asia Life Sciences, Goodwin and Chairwoman, BayHelix

Jason Peng
Partner, McKinsey & Company

Jean-Christophe Pointeau
President, China, Pfizer Inc.

Maha Radhakrishnan, M.D.
Executive Partner, Sofinnova Investments

Albert Ren, Ph.D.
VP, Strategy & Business Development, China, Pfizer

Joan Shen, M.D., Ph.D.
Founder & CEO, NeuShen Therapeutics

David Shen, Ph.D.
Founder & CEO, Proteologix

Stella Shi
Founder & CEO, RONA Therapeutics

Yonghui Shi, Ph.D.
SVP, Chief Strategy and Corporate Development Officer, MicroTech Medical

Lei Shi, Ph.D.
Partner, Eight Roads Ventures

Wayne Shi
President, Greater China, Sanofi

Randall Sunberg
Partner, Baker & McKenzie

Xin Tao
Partner & Chair, U.S. FDA Practice, Baker & McKenzie

Jody Tian
Partner, McKinsey & Co.

Sam Waksal, Ph.D.
Chairman & CEO, Graviton Bioscience

Bing Wang, Ph.D.
CFO, Akeso Biopharma

Jin Wang
Partner & Co-Leader, China Healthcare Practice, McKinsey & Co.

Xuelin (Steve) Wang
Partner, Davis Polk

Kevin Wu, Ph.D.
Partner, McKinsey & Company

Chengbin Wu, Ph.D.
Founder and CEO, EpimAb Biotherapeutics

Jie Wu
Head, APAC, MPM BioImpact

Xiaobin Wu, Ph.D.
President & Chief Operating Officer, BeiGene Ltd.

Megan Xu
Director, Search & Evaluation, Novartis

Stella Xu, Ph.D.
Managing Partner, Quan Capital

Jing Xu, Ph.D.
Principal, LYFE Capital

Jenny Yang, Ph.D.
Senior Director, Global Search & Evaluation, Novo Nordisk

Albert Yu, Ph.D.
Founder & Chairman, Hai Kang Life, and Chairman, Hong Kong Biotechnology Organization (HKBIO)

Yuan Yuan, Ph.D.
Principal, Eight Roads Ventures

Dan Zhang, M.D.
Co-Chairman, Hillgene

Hua Zhang
VP, Head of Science and Regulatory Affairs, RDPAC

Hong Zhang
Partner, Baker & McKenzie

Jimmy Zhang, Ph.D.
Former Chairman, BayHelix, and Head of Business Development, Frontier Biotechnologies

John Zhu, Ph.D.
Founder & CEO, Duality Biologics

Jieyu Zou
Partner, Lilly Asia Venture

2024 Sponsors

• 8 Eight Roads
• Lilly Asia Ventures
• MPM Bio Impact
• Panacea Venture
• Pivotal
• Qiming Venture Partners
• Quan
• Roche
• Sidley
• Sofinnova
• Veeva
• Enmore Bio
• Lingmed
• Lychee
• MSQ
• Pharma
• RDPAC